Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117138) titled 'A Study Comparing Two Methods for Cervical Cancer Screening in Women in Delhi' on Sept. 7.
Study Type: Interventional
Study Design:
Other Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable
Primary Sponsor: Indian Council of Medical Research
Intervention:
Intervention1: Primary HPV-DNA-based cervical cancer screening: Eligible women aged 30 65 years will undergo primary HPV-DNA-based cervical cancer screening in the community. Women will be allowed to choose either self-collected vaginal sampling or provider-co...